Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002280459 | SCV002568585 | pathogenic | not provided | 2022-05-09 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense-mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26507355, 33247512, 32410215, 23188108) |
Labcorp Genetics |
RCV002280459 | SCV003442392 | pathogenic | not provided | 2022-10-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1703337). This premature translational stop signal has been observed in individual(s) with EFTUD2-related conditions (PMID: 23188108, 32410215). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg569*) in the EFTUD2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EFTUD2 are known to be pathogenic (PMID: 24999515, 26507355). |
Duke University Health System Sequencing Clinic, |
RCV003223434 | SCV003918985 | pathogenic | Mandibulofacial dysostosis-microcephaly syndrome | 2023-04-20 | criteria provided, single submitter | research |